Biomagnification Open Access Articles
Biomagnification, additionally called bioamplification or biological magnification, is any concentration of a poison, like pesticides, within the
tissues of tolerant organisms at in turn higher levels in a very organic phenomenon. Biological magnification typically refers to the method whereby bound substances like pesticides or serious metals work their manner into lakes, rivers and therefore the ocean, then move up the organic phenomenon in increasingly larger concentrations as they're incorporated into the diet of aquatic organisms like animate being, that successively square measure eaten up maybe by fish, that then could also be eaten up by larger fish, giant birds, animals, or humans. The substances become more and more focused in
tissues or internal organs as they move up the chain. Bioaccumulants square measure substances that increase in concentration in living organisms as they absorb contaminated air, water, or food as a result of the substances square measure terribly slowly metabolized or excreted.
Biomagnification, also known as bioamplification or biological magnification, is any concentration of a toxin, such as pesticides, in the
tissues of tolerant organisms at successively higher levels in a food chain.
There are two main groups of substances that biomagnify. Both are lipophilic and not easily degraded. Novel organic substances are not easily degraded because organisms lack previous exposure and have thus not evolved specific
detoxification and excretion mechanisms, as there has been no selection pressure from them. These substances are consequently known as "persistent organic pollutants" or POPs.
High Impact List of Articles
-
Prevalence of aminoglycoside resistance genes in Pseudomonas aeruginosa isolated from a tertiary care hospital in Makkah, KSA
Atif H Asghar & Omar B Ahmed*
Research Article: Clinical Practice
-
Prevalence of aminoglycoside resistance genes in Pseudomonas aeruginosa isolated from a tertiary care hospital in Makkah, KSA
Atif H Asghar & Omar B Ahmed*
Research Article: Clinical Practice
-
Osteoarthritis in 2010
Jean-Pierre Pelletier, Johanne Martel-Pelletier and Jean-Yves Reginster
Foreword: Clinical Practice
-
Osteoarthritis in 2010
Jean-Pierre Pelletier, Johanne Martel-Pelletier and Jean-Yves Reginster
Foreword: Clinical Practice
-
Opioids for chronic noncancer pain
Gary McCleane
Review Article: Clinical Practice
-
Opioids for chronic noncancer pain
Gary McCleane
Review Article: Clinical Practice
-
What is the clinical utility of interferon-α release assays for the diagnosis of TB in high-TB-burden countries?
Peter Daley and Poorvi Chordia
Review Article: Clinical Practice
-
What is the clinical utility of interferon-α release assays for the diagnosis of TB in high-TB-burden countries?
Peter Daley and Poorvi Chordia
Review Article: Clinical Practice
-
From vector toxicity to successful clinical evaluation: highlights of the 2nd annual meeting of the British Society for Gene Therapy
Lisa D Cooper, Martin L Read, Karen Doyle, Ann Logan and Ana Maria Gonzalez
Conference Scene: Clinical Practice
-
From vector toxicity to successful clinical evaluation: highlights of the 2nd annual meeting of the British Society for Gene Therapy
Lisa D Cooper, Martin L Read, Karen Doyle, Ann Logan and Ana Maria Gonzalez
Conference Scene: Clinical Practice
Relevant Topics in Clinical